Diabetes and endocrinology
![Empower your patients: a guide to diabetes and CGM](https://s3-eu-west-2.amazonaws.com/images.thepharmacist.co.uk/wp-media-folder-the-pharmacist/wp-content/uploads/2024/07/pha-dexcom.jpg)
![](https://www.thepharmacist.co.uk/wp-content/themes/thepharmacist/assets/img/flash.png)
Empower your patients: a guide to diabetes and CGM
Exercise reduces risk of kidney disease in patients with type 2 diabetes
Government extends GLP-1 RA shortage warning until end of 2024
NICE recommends ‘game changer’ wearable tech for type 1 diabetes
Study finds potential for weekly insulin injections in diabetes care
MHRA finds fake Ozempic pens in UK supply chain
PCN to use conversation app to improve medicines adherence
Tirzepatide approval sparks hope though supply warnings remain
‘Vital’ to improve diabetes medication supply and staff resource before winter
Total cost of antidiabetic drugs more than doubles in eight years
Later breakfast linked to increased type 2 diabetes risk
NICE lowers threshold for weight-loss surgery referrals
Regulators issue statement on GLP-1 RA prescribing
Pharmacists and GPs call for diabetes drug supply protection
GLP-1 receptor agonists shortage expected until 2025
Superdrug deal for Thriva at-home and in-store testing
Researchers uncover genetic combination that influences diabetes risk
Only 46% of diabetes patients had all recommended checks last year
UV light bandage could reduce antibiotic use
Study links autoimmune disease risk to smoking and obesity
Be alert to lung complications with type 2 diabetes, charity warns
More Stories